ZFP36 and myocardial infarction: Our study indicates that QXJYG treatment significantly enhances cardiac function, alleviates cardiac pathological changes, and suppresses inflammatory factors levels in a myocardial infarction-induced mouse model, potentially through modulation of the MK2/TTP signaling pathway.